Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Atossa Genetics Inc
ATOSCurrent price
0.76 USD
-0.013 USD (-1.66%)
Last closed
0.74 USD
Company
www.atossatherapeutics.com
ISIN
US04962H5063
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
94 629 936 USD
Yield for 12 month
-50.58 %
1Y
3Y
5Y
10Y
15Y
ATOS
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington. Address: 107 Spring Street, Seattle, WA, United States, 98104
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.08 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-23 000 USD
Current Quarter
–
Last Quarter
–
Key Figures ATOS
1 year
3 years
5 years
10 years
EBITDA
-27 604 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-19.99 %
PEG Ratio
–
Return On Equity TTM
-31.39 %
Wall Street Target Price
6.08 USD
Revenue TTM
–
Book Value
0.55 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.20 USD
Diluted Eps TTM
-0.20 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ATOS
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ATOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:12
Payout Ratio TTM
–
Last Split Date
20.04.2018
Stock Valuation ATOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
2.01
Price Book MRQ
1.33
Financials ATOS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATOS
For 52 weeks
0.55 USD
1.81 USD
50 Day MA
0.72 USD
Shares Short Prior Month
8 580 955
200 Day MA
1.12 USD
Short Ratio
15.27
Shares Short
8 097 901
Short Percent
6.27 %
BeatStart